Changes related to "Pegylated liposomal doxorubicin (Doxil)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 00:11, 23 June 2018
   
Page name:

22 June 2018

 m   22:32  Diffuse large B-cell lymphoma‎‎ (2 changes | history) . . (-927). . [Jwarner‎ (2×)]
 m    22:32 (cur | prev) . . (+49). . Jwarner (talk | contribs) (R-CHOP-14 {{#subobject:fc3bde|Regimen=1}})
 m    19:16 (cur | prev) . . (-976). . Jwarner (talk | contribs) (R-CVP {{#subobject:1b5df7|Regimen=1}})
 m   22:24  Multiple myeloma‎ (diff | hist) . . (+1,337). . Jwarner (talk | contribs) (Bortezomib & Dexamethasone {{#subobject:899402|Regimen=1}})
 m   15:42  Ovarian cancer‎ (diff | hist) . . (-60). . Jwarner (talk | contribs)

20 June 2018

     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:42  Uterine cancer‎ (diff | hist) . . (+30). . Jwarner (talk | contribs)
 m   11:11  Multiple myeloma‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   10:46  Esophageal cancer‎ (diff | hist) . . (+180). . Jwarner (talk | contribs) (FOLFOX-C {{#subobject:e51095|Regimen=1}})

19 June 2018

 m   23:01  Esophageal cancer‎ (diff | hist) . . (-35). . Jwarner (talk | contribs)
 m   17:36  HIV-associated lymphoma‎‎ (2 changes | history) . . (+195). . [Jwarner‎ (2×)]
 m    17:36 (cur | prev) . . (+2,688). . Jwarner (talk | contribs) (Upfront therapy)
 m    17:35 (cur | prev) . . (-2,493). . Jwarner (talk | contribs) (DR-COP {{#subobject:ec091e|Regimen=1}})
 m   17:30  Vascular sarcoma‎ (diff | hist) . . (+20). . Jwarner (talk | contribs) (Kaposi sarcoma, all lines of therapy)
 m   17:29  Ovarian cancer‎ (diff | hist) . . (+66). . Jwarner (talk | contribs) (Relapsed or recurrent disease, platinum-resistant)
 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   11:26  Multiple myeloma‎ (diff | hist) . . (+1,082). . Jwarner (talk | contribs)

18 June 2018

     23:14  Esophageal cancer‎‎ (6 changes | history) . . (+3,152). . [Jwarner‎ (2×); Nainasingh‎ (4×)]
 m    23:14 (cur | prev) . . (+149). . Jwarner (talk | contribs)
 m    22:00 (cur | prev) . . (+9). . Jwarner (talk | contribs) (Capecitabine, Paclitaxel, RT {{#subobject:17bbec|Regimen=1}})
      18:41 (cur | prev) . . (+1,269). . Nainasingh (talk | contribs) (Regimen  ) (Tag: Visual edit)
      18:09 (cur | prev) . . (+635). . Nainasingh (talk | contribs) (Regimen  ) (Tag: Visual edit)
      17:50 (cur | prev) . . (+1,066). . Nainasingh (talk | contribs) (Variant #1  ) (Tag: Visual edit)
      17:10 (cur | prev) . . (+24). . Nainasingh (talk | contribs) (Chemotherapy) (Tag: Visual edit)
 m   20:56  Hodgkin lymphoma‎‎ (2 changes | history) . . (+148). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Subsequent treatment)
 m    20:55 (cur | prev) . . (+144). . Jwarner (talk | contribs) (Consolidation after upfront therapy)
 m   17:42  Multiple myeloma‎‎ (5 changes | history) . . (-83). . [Jwarner‎ (5×)]
 m    17:42 (cur | prev) . . (-94). . Jwarner (talk | contribs)
 m    17:41 (cur | prev) . . (+3,384). . Jwarner (talk | contribs) (VT {{#subobject:e94510|Regimen=1}})
 m    17:37 (cur | prev) . . (-3,293). . Jwarner (talk | contribs) (Bortezomib & Prednisone {{#subobject:ee2988|Regimen=1}})
 m    17:13 (cur | prev) . . (+2,087). . Jwarner (talk | contribs) (PAD {{#subobject:955a56|Regimen=1}})
 m    16:58 (cur | prev) . . (-2,167). . Jwarner (talk | contribs) (BDD {{#subobject:6ab815|Regimen=1}})

17 June 2018

 m   20:33  Hodgkin lymphoma‎‎ (2 changes | history) . . (+3,054). . [Jwarner‎ (2×)]
 m    20:33 (cur | prev) . . (+2,141). . Jwarner (talk | contribs) (ABVD {{#subobject:8b9772|Regimen=1}})
 m    20:19 (cur | prev) . . (+913). . Jwarner (talk | contribs) (Escalated BEACOPP {{#subobject:ca99d7|Regimen=1}})
 m   16:19  Breast cancer‎‎ (5 changes | history) . . (+2,908). . [Jwarner‎ (5×)]
 m    16:19 (cur | prev) . . (+1,300). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:47db8e|Regimen=1}})
 m    16:07 (cur | prev) . . (+315). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:45c144|Regimen=1}})
 m    16:04 (cur | prev) . . (+314). . Jwarner (talk | contribs) (Docetaxel monotherapy {{#subobject:1216fd|Regimen=1}})
 m    16:02 (cur | prev) . . (+691). . Jwarner (talk | contribs) (AC {{#subobject:647f67|Regimen=1}})
 m    15:48 (cur | prev) . . (+288). . Jwarner (talk | contribs) (AC {{#subobject:77b0fd|Regimen=1}})